Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Ringworm of the body and scalp is treated with antifungal creams and oral medication, and children with scalp ringworm don't need to miss school.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some drugs may help treat both COVID-19 and radiation injury.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The treatment might help COVID-19 related hair loss, but more research is needed.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

COVID-19 can cause long-lasting non-respiratory symptoms, especially in women.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.